M&A Deal Summary

CSI Acquires Allium Medical Solutions - WIRION Embolic Protection System

On August 5, 2019, CSI acquired medical products company Allium Medical Solutions - WIRION Embolic Protection System from Allmed Solutions

Acquisition Highlights
  • This is CSI’s 1st transaction in the Medical Products sector.
  • This is CSI’s 1st transaction in Israel.

M&A Deal Summary

Date 2019-08-05
Target Allium Medical Solutions - WIRION Embolic Protection System
Sector Medical Products
Buyer(s) CSI
Sellers(s) Allmed Solutions
Deal Type Divestiture

Target

Allium Medical Solutions - WIRION Embolic Protection System

Caesarea, Israel
Allium Medical Solutions Ltd. - WIRION Embolic Protection System is a distal embolic protection filter used to capture debris that can be associated with all types of peripheral vascular intervention (PVI) procedures. Physicians typically use embolic protection devices in vessels located above the knee with long lesions, high plaque burden, and poor runoff.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

CSI

St. Paul, Minnesota, United States

Category Company
Founded 1989
Sector Medical Products
Revenue 236M USD (2022)
DESCRIPTION
Entrance to Cardiovascular Systems' offices in Roseville, Minnesota.
Entrance to Cardiovascular Systems' offices in Roseville, Minnesota.

CSI is a medical device company focused on developing and commercializing minimally invasive treatment solutions for vascular disease. Its primary products include catheter-based platforms, such as the Stealth 360° peripheral artery disease (PAD) System, Diamondback 360° PAD System, and Diamondback Predator 360° PAD System that are used for the treatment of a range of plaque types in leg arteries above and below the knee. CSI was founded in 1989 and is based in St. Paul, Minnesota.


DEAL STATS #
Overall 2 of 4
Sector: Medical Products M&A 1 of 2
Type: Divestiture M&A Deals 1 of 2
Country: Israel M&A 1 of 1
Year: 2019 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-02-25 Replidyne

Louisville, Colorado, United States

Replidyne, Inc. is a biopharmaceutical company focused on the discovery and development of new antimicrobial drugs.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-22 WavePoint Medical - Peripheral Support Catheters

Salt Lake City, Utah, United States

WavePoint Medical - Peripheral Support Catheters are used during peripheral vascular intervention (PVI) procedures for guidewire support to enable lesion crossing, as well as for guidewire exchanges. WavePoint Medical's Peripheral Support Catheters is based in Salt Lake City, Utah.

Buy -

Seller(S) 1

SELLER

Allmed Solutions

Caesarea, Israel

Category Company
Founded 2004
Sector Medical Products
Employees22
Revenue 6M ILS (2021)
DESCRIPTION

Allmed Solutions develops, manufactures and markets minimally invasive products internationally in various medical disciplines. These innovative products serve the need for minimally invasive interventions benefitting the patient by improving their recovery process and shortening it. Allmed Solutions’ products are used by physicians to treat a wide range of diseases and patients worldwide. Allmed Solutions was founded in 2004 and is based in Caesarea, Israel.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Israel M&A 1 of 1
Year: 2019 M&A 1 of 1